MUMBAI: Sputnik V Covid-19 of Russia vaccine, which reported an efficiency of more than 95%, will be twice as cheap as Pfizer and Moderna with similar positive results. Sputnik V, developed by Gamaleya Institute Y RDIF (Russian Direct Investment Fund), will be priced at less than $ 20 per person …
Read More »Russia may be the first to announce doomsday data
Alexander Gintsburg, director of the Gamaleya Institute that produced the Sputnik V vaccine, told Reuters that the pace of its development was necessary in the “wartime” conditions of a pandemic, but that no corners were being cut. Russia has moved forward with its potential COVID-19 vaccine at full speed with …
Read More »